On April 15, 2023, Beyond Cells closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,300 KRW | -1.10% | -16.78% | -16.67% |
16/05 | Amicogen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
20/03 | Amicogen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-16.67% | 25Cr | |
+16.26% | 12TCr | |
+21.53% | 12TCr | |
+22.18% | 2.7TCr | |
-21.77% | 2.04TCr | |
-16.89% | 1.64TCr | |
-18.07% | 1.59TCr | |
-44.74% | 1.56TCr | |
+61.42% | 1.49TCr | |
+3.14% | 1.36TCr |
- Stock Market
- Equities
- A092040 Stock
- News Amicogen, Inc.
- Beyond Cells announced that it has received KRW 3 billion in funding from Amicogen, Inc.